Literature DB >> 2285644

Effect of ketanserin on pain perception in arterial hypertension.

C Rosa1, S Ghione.   

Abstract

An association between increased tolerance to pain and arterial hypertension has been reported in experimental animals and confirmed in humans. The underlying mechanisms remain elusive. We have recently reported that diuretics and beta-blocking treatment do not influence pain sensitivity, despite significant reductions in arterial blood pressure. In the present study, ketanserin was evaluated. As in previous work, pain perception was assessed with a tooth pulp tester. Ten hypertensive subjects were studied basally, after 15 days and after 3 months of ketanserin treatment (20 mg twice daily). Significant reductions in arterial blood pressure and of pain thresholds were observed, but no correlation between these changes occurred. These preliminary data indicate that, contrary to other hypotensive drugs, ketanserin tends to decrease or reverse the abnormality in pain modulation observed in hypertensive patients. The lack of a correlation between effects on blood pressure and pain sensitivity seems, however, to favor the hypothesis of two independent underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285644     DOI: 10.1007/bf00053445

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  12 in total

Review 1.  Brainstem control of spinal pain-transmission neurons.

Authors:  H L Fields; A I Basbaum
Journal:  Annu Rev Physiol       Date:  1978       Impact factor: 19.318

2.  Evidence for serotonin-S2 receptor involvement in analgesia in humans.

Authors:  G Sandrini; E Alfonsi; C De Rysky; S Marini; F Facchinetti; G Nappi
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

3.  Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats.

Authors:  N Zamir; M Segal
Journal:  Brain Res       Date:  1979-01-05       Impact factor: 3.252

4.  Arterial hypertension is associated with hypalgesia in humans.

Authors:  S Ghione; C Rosa; L Mezzasalma; E Panattoni
Journal:  Hypertension       Date:  1988-11       Impact factor: 10.190

5.  Naloxone reversible decrease in pain sensitivity in young and adult spontaneously hypertensive rats.

Authors:  J M Saavedra
Journal:  Brain Res       Date:  1981-03-23       Impact factor: 3.252

6.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

Review 7.  The relationship between cardiovascular and pain regulatory systems.

Authors:  N Zamir; W Maixner
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

8.  Observations on pain perception and hypertension in spontaneously hypertensive rats.

Authors:  J M Sitsen; W de Jong
Journal:  Clin Exp Hypertens A       Date:  1984

9.  In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

Authors:  P M Laduron; P F Janssen; J E Leysen
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

Review 10.  Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

Authors:  P Vanhoutte; A Amery; W Birkenhäger; A Breckenridge; F Bühler; A Distler; J Dormandy; A Doyle; E Frohlich; L Hansson
Journal:  Hypertension       Date:  1988-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.